They are being very tight lipped atm, which is allowing the SP to be step laddered up and down at will by the grubs.
Wouldn't have a clue whether that is a positive or a negative. It is a brave investor who automatically accepts that it must be a positive. They are still very pre-clinical and any hiccup could be disastrous. [Clue: Solid cancer animal data is getting later by the day and nothing has been announced wrt the promised follow up to the previous pharmacokinetics news.]
A lot of faith required here.
Ann: PAT-DX1 Clinical Target Indications Confirmed, page-146
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
